Kees Melief

Company: ISA Pharmaceuticals

Job title: Chief Scientific Officer

Seminars:

Achieving Sustained Treatment Response: The Need for Immunotherapy in Chronic HBV 1:30 pm

• Evaluating the role of T-cells in clearing virus infections, including HBV epitope targets for CD4+ and CD8+ T cells • Understanding the analogy between HPV and HBV chronic infections with attention to the special role of the liver • Reviewing the synthetic Long Peptide vaccine technology in HBV • Exploring the relationship between immune…Read more

day: Day Two